Tanguy Y Seiwert (Tanguy Seiwert)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 17

Top Topics

Locally Advanced

Advanced Non Small Cell Lung Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Journal for immunotherapy of cancer

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Neil D Gross, Tanguy Y Seiwert
Neoadjuvant immunotherapy is safe before surgery in head and neck squamous cell carcinoma. Is it time to challenge the standard-of-care? Cancer 130 (6) (2024)
Neil D Gross, Tanguy Y Seiwert
Neoadjuvant immunotherapy is safe before surgery in head and neck squamous cell carcinoma. Is it time to challenge the standard-of-care? Cancer 130 (6) (2024)
Neil D Gross, Tanguy Y Seiwert
Neoadjuvant immunotherapy is safe before surgery in head and neck squamous cell carcinoma. Is it time to challenge the standard-of-care? Cancer (2024)
Neil D Gross, Tanguy Y Seiwert
Neoadjuvant immunotherapy is safe before surgery in head and neck squamous cell carcinoma. Is it time to challenge the standard-of-care? Cancer 130 (6) (2024)
Pritam Sadhukhan, Tanguy Y Seiwert
The role of macrophages in the tumor microenvironment and tumor metabolism. Seminars in immunopathology (2023)
Jacob J Adashek, Surendra Sapkota, Rodrigo de Castro Luna, Tanguy Y Seiwert
Complete response to alectinib in ALK-fusion metastatic salivary ductal carcinoma. NPJ precision oncology 7 (1) (2023)
Deborah X Xie, Carmen Kut, Harry Quon, Tanguy Y Seiwert, Gypsyamber D'Souza, Carole Fakhry
Clinical Uncertainties of Circulating Tumor DNA in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma in the Absence of National Comprehensive Cancer Network Guidelines. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Rana Rais, Kathryn M Lemberg, Lukáš Tenora, Matthew L Arwood, Arindom Pal, Jesse Alt, Ying Wu, Jenny Lam, Joanna Marie H Aguilar, Liang Zhao, Diane E Peters, Carolyn Tallon, Rajeev Pandey, Ajit G Thomas, Ranjeet P Dash, Tanguy Y Seiwert, Pavel Majer, Robert D Leone, Jonathan D Powell, Barbara S Slusher
Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug. Science advances 8 (46) (2022)
Robert I Haddad, Tanguy Y Seiwert, Laura Q M Chow, Shilpa Gupta, Jared Weiss, Iris Gluck, Joseph P Eder, Barbara Burtness, Makoto Tahara, Bhumsuk Keam, Hyunseok Kang, Kei Muro, Andrew Albright, Robin Mogg, Mark Ayers, Lingkang Huang, Jared Lunceford, Razvan Cristescu, Jonathan Cheng, Ranee Mehra
Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma. Journal for immunotherapy of cancer 10 (2) (2022)
Stefanie Seo, Lisa M Rooper, Tanguy Y Seiwert, Carole A Fakhry
Spontaneous regression of an human papillomavirus-positive oropharyngeal squamous cell carcinoma. Head & neck (2022)
Corey C Foster, Tanguy Y Seiwert
Reply to "Guarantee-time bias in studies on the relationship between immune-related adverse events and antitumor activity". Cancer 128 (13) (2022)
Charu Aggarwal, Nabil F Saba, Alain Patrick Algazi, Ammar Sukari, Tanguy Y Seiwert, Missak Haigentz, Mercedes Porosnicu, Marcelo R Bonomi, Jean Boyer, Mark T Esser, Lily I Cheng, Sonia Agrawal, Emily C Jennings, Nicholas M Durham, Karl Fraser, Delphine Lissa, Maozhen Gong, Natalia Ceaicovscaia, Amaya Gasco Hernandez, Rakesh Kumar
Safety and Efficacy of MEDI0457 Plus Durvalumab in Patients With Human Papillomavirus-associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Michael Hwang, Jenna Vanliere Canzoniero, Samuel Rosner, Guangfan Zhang, James R White, Zineb Belcaid, Christopher Cherry, Archana Balan, Gavin Pereira, Alexandria Curry, Noushin Niknafs, Jiajia Zhang, Kellie N Smith, Lavanya Sivapalan, Jamie E Chaft, Joshua E Reuss, Kristen Marrone, Joseph C Murray, Qing Kay Li, Vincent Lam, Benjamin P Levy, Christine Hann, Victor E Velculescu, Julie R Brahmer, Patrick M Forde, Tanguy Y Seiwert, Valsamo Anagnostou
Peripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapy. Journal for immunotherapy of cancer 10 (6) (2022)
Anthony J Cmelak, Matthew J Ferris, Allen M Chen, Tanguy Y Seiwert, Barbara Burtness
Treatment De-intensification for HPV-Positive Oropharynx Cancer: What Is Currently Acceptable? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (24) (2021)
Sara E Kochanny, Francis P Worden, Douglas R Adkins, Dean W Lim, Julie E Bauman, Stephanie A Wagner, Ryan J Brisson, Theodore G Karrison, Walter M Stadler, Everett E Vokes, Tanguy Y Seiwert
A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma. Cancer 126 (10) (2020)
Tanguy Y Seiwert, Sara E Kochanny, Kevin Wood, Francis P Worden, Douglas R Adkins, James L Wade, Bethany G Sleckman, Daniel Anderson, Ryan J Brisson, Theodore Karrison, Walter M Stadler, Everett E Vokes
A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study. Cancer 126 (14) (2020)
Razvan Cristescu, Robin Mogg, Mark Ayers, Andrew Albright, Erin Murphy, Jennifer Yearley, Xinwei Sher, Xiao Qiao Liu, Hongchao Lu, Michael Nebozhyn, Chunsheng Zhang, Jared K Lunceford, Andrew Joe, Jonathan Cheng, Andrea L Webber, Nageatte Ibrahim, Elizabeth R Plimack, Patrick A Ott, Tanguy Y Seiwert, Antoni Ribas, Terrill K McClanahan, Joanne E Tomassini, Andrey Loboda, David Kaufman
Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy. Science (New York, N.Y.) 362 (6411) (2018)